184 related articles for article (PubMed ID: 33679129)
21. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer.
Torres HA; Rallapalli V; Saxena A; Granwehr BP; Viola GM; Ariza-Heredia E; Adachi JA; Chemaly RF; Marfatia R; Jiang Y; Mahale P; Kyvernitakis A; Fanale MA; Mulanovich V
Clin Microbiol Infect; 2014 Oct; 20(10):O672-9. PubMed ID: 24529214
[TBL] [Abstract][Full Text] [Related]
22. Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naïve individuals in a tertiary care hospital in Beijing, China.
Liu L; Dai L; Yao J; Pan P; Li L; Liu Z; An X; Sun L; Wu H; Su B; Zhang T
AIDS; 2019 Oct; 33(12):1945-1947. PubMed ID: 31491787
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Human Immunodeficiency Virus-1 Transmission Clusters and Transmitted Drug-Resistant Mutations in Croatia from 2019 to 2022.
Planinić A; Begovac J; Rokić F; Šimičić P; Oroz M; Jakovac K; Vugrek O; Zidovec-Lepej S
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140649
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naïve chronically infected Brazilian blood donors.
Pessôa R; Sanabani SS
PLoS One; 2017; 12(9):e0185559. PubMed ID: 28953964
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.
Aghokeng AF; Ngo-Giang-Huong N; Huynh THK; Dagnra AY; D'Aquin Toni T; Maiga AI; Dramane K; Eymard-Duvernay S; Chaix ML; Calvez V; Descamps D;
J Antimicrob Chemother; 2024 May; 79(5):1164-1168. PubMed ID: 38546752
[TBL] [Abstract][Full Text] [Related]
26. High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.
Mboumba Bouassa RS; Mossoro-Kpinde CD; Gody JC; Veyer D; Péré H; Matta M; Robin L; Grésenguet G; Charpentier C; Bélec L
J Antimicrob Chemother; 2019 Jul; 74(7):2030-2038. PubMed ID: 30891603
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance.
Mbhele N; Chimukangara B; Gordon M
Int J Antimicrob Agents; 2021 May; 57(5):106343. PubMed ID: 33852932
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 Diversity and Drug Resistance in Treatment-Naïve Children and Adolescents from Rio de Janeiro, Brazil.
de Azevedo SSD; Delatorre E; Gaido CM; Silva-de-Jesus C; Guimarães ML; Couto-Fernandez JC; Morgado MG
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016383
[TBL] [Abstract][Full Text] [Related]
29. Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting.
Chehadeh W; Albaksami O; Al-Shammari S
Antivir Chem Chemother; 2020; 28():2040206620927908. PubMed ID: 32434393
[TBL] [Abstract][Full Text] [Related]
30. Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013.
Stekler JD; McKernan J; Milne R; Tapia KA; Mykhalchenko K; Holte S; Maenza J; Stevens CE; Buskin SE; Mullins JI; Frenkel LM; Collier AC
Antivir Ther; 2015; 20(1):77-80. PubMed ID: 24831260
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon.
Mikasi SG; Gichana JO; Van der Walt C; Brado D; Obasa AE; Njenda D; Messembe M; Lyonga E; Assoumou O; Cloete R; Ikomey GM; Jacobs GB
AIDS Res Hum Retroviruses; 2020 May; 36(5):450-455. PubMed ID: 31830799
[TBL] [Abstract][Full Text] [Related]
32. Contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapy.
Gibson RM; Weber J; Winner D; Miller MD; Quiñones-Mateu ME
PLoS One; 2014; 9(8):e104512. PubMed ID: 25110880
[TBL] [Abstract][Full Text] [Related]
33. Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000-2014.
Moscona R; Ram D; Wax M; Bucris E; Levy I; Mendelson E; Mor O
J Int AIDS Soc; 2017 Aug; 20(1):21846. PubMed ID: 28799325
[TBL] [Abstract][Full Text] [Related]
34. Primary resistance to integrase inhibitors in Shenzhen.
Zhu Y; Huang Y; Zheng C; Tang J; Zeng G; Xie W; Wang H; Zhang L; Liu S; Zhang Y; Tan W; Tan J; Jiang L; He Y; Xu L; Yang Z; Zhao J
J Antimicrob Chemother; 2023 Feb; 78(2):546-549. PubMed ID: 36585770
[TBL] [Abstract][Full Text] [Related]
35. The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance.
Liang J; Mesplède T; Oliveira M; Anstett K; Wainberg MA
J Virol; 2015 Nov; 89(22):11269-74. PubMed ID: 26311878
[TBL] [Abstract][Full Text] [Related]
36. A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
Le Hingrat Q; Collin G; Lê M; Peytavin G; Visseaux B; Bertine M; Tubiana R; Karmochkine M; Valin N; Collin F; Lemaignen A; Bernard L; Damond F; Matheron S; Descamps D; Charpentier C;
Clin Infect Dis; 2019 Aug; 69(4):657-667. PubMed ID: 30383215
[TBL] [Abstract][Full Text] [Related]
37. Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs.
Smith SJ; Zhao XZ; Passos DO; Lyumkis D; Burke TR; Hughes SH
Viruses; 2021 Jan; 13(2):. PubMed ID: 33572956
[TBL] [Abstract][Full Text] [Related]
38. Absence of Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naïve and Experienced Individuals from Western India.
Karade S; Sen S; Sashindran VK
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):567-571. PubMed ID: 30793915
[TBL] [Abstract][Full Text] [Related]
39. Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018.
Lan Y; Li L; Chen W; Deng X; Li J; Fan Q; Cai X; Cai W; Hu F
Infect Drug Resist; 2020; 13():4389-4394. PubMed ID: 33324078
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
De Francesco MA; Izzo I; Properzi M; Gargiulo F; Caccuri F; Quiros-Roldan E; Castelli F; Caruso A; Focà E
AIDS Res Hum Retroviruses; 2018 Jul; 34(7):570-574. PubMed ID: 29631420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
